These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2008-001237-95||Aprepitant in the prevention of delayed emesis induced by moderately emetogenic chemotherapy (cyclophosphamide + anthracycline) in breast cancer patients: a double-blind randomized study||not-yet-due|
|Ongoing||2008-001339-37||Aprepitant in the prevention of cisplatin-induced delayed emesis: a double-blind randomized study||not-yet-due|
|Ongoing||2022-000391-19||A Single Arm Phase II Study of CAbozantinib in relapsing IDH-1wt, MET amplified Glioblastoma: (“CAT” Study) Sperimentazione clinica di fase 2 a singolo braccio con CAbozantinib nel glioblastoma rec...||not-yet-due|